BREZTRI
NDC 0310-4616, budesonide, glycopyrrolate, and formoterol fumarate, aerosol, metered, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-4616
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- AEROSOL, METERED
- Route
- RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212122
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-4616 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUDESONIDE160 ug/1
- GLYCOPYRROLATE9 ug/1
- FORMOTEROL4.8 ug/1
Pharmacologic classes
Adrenergic beta2-Agonists [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; beta2-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-4616-12 | 00310461612 | 120 AEROSOL, METERED in 1 INHALER (0310-4616-12) |
| 0310-4616-28 | 00310461628 | 28 AEROSOL, METERED in 1 INHALER (0310-4616-28) |
| 0310-4616-39 | 00310461639 | 28 AEROSOL, METERED in 1 INHALER (0310-4616-39) |
Linked data
RxNorm, label and prices
RxNorm concepts
- 238732828 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT Metered Dose Inhaler [Breztri] (SBD)
- 2387331120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT Metered Dose Inhaler [Breztri] (SBD)
Related lookups
FDA label sections
GET /v1/drugs/labels/715433dc-cb2b-43ea-b6df-c5b4177adc6cNADAC price for package 00310461612
GET /v1/drugs/nadac/00310461612NADAC price for package 00310461639
GET /v1/drugs/nadac/00310461639
Use it
Look up 0310-4616 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-4616 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-4616. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.